Ionis Pharma Urges Investors to Reject the Below-the-Market Offer By Post author:Sam Post published:August 23, 2017 Post category:BioPharma August 24, 2017By Mark Terry… Source: BioSpace You Might Also Like Bay Area's ChemoCentryx Gets Up to $100M in New Capital Commitments January 3, 2018 Why Pfizer Will Not Make Another Mega M&A Deal Anytime Soon March 14, 2017 Abivax First-Half 2017 Financial Results And Update September 21, 2017
